Analgesic & anti-inflammatory effects in juvenile RA & soft-tissue injuries eg, sprains & strains. Analgesic effect in relief of mild to moderate pain eg, dental pain. Symptomatic relief of headache. Short-term use for pyrexia in childn >1 yr.
20 mg/kg daily in divided doses. Childn 8-12 yr 10 mL tds-qds, 3-7 yr 5 mL tds-qds, 1-2 yr 2.5 mL tds-qds. Juvenile RA Up to 40 mg/kg daily in divided doses. Not to exceed 4 doses in 24 hr.
Severe skin reactions eg, exfoliative dermatitis, TEN, SJS. Increased risk of GI ulceration, bleeding, perforation in patients w/ prior history of serious GI events & other risk factors associated w/ PUD eg, alcoholism, smoking, corticosteroid therapy; serious CV events eg, MI. Patients w/ HTN; fluid retention or heart failure; asthma or aspirin-sensitive asthma; cardiac impairment. Closely monitor BP during & at regular intervals thereafter. Concurrent use w/ aspirin. Hepatic or renal impairment. Not recommended in childn <7 kg. Elderly & debilitated patients.
Sign Out
